Ventilator Associated Pneumonia

MASTERMIND-Pneumonia Study (Also Known as Pneumonia Direct Pilot)

Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia

Macrophage Programing in Acute Lung Injury: MiniBAL

Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.

The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days

A Multi-Center Diagnostic Stewardship Program to Improve Respiratory Culture Utilization in Critically Ill Children

Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia

Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care Units

Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit

Optimizing Enteral Nutrition Regimen for Critically Ill Patients

7-days Versus 14 Days of Antibiotics Therapy for Ventilator Associated Pneumonia

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Diagnostic Stewardship for Ventilator Associated Pneumonia

Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL

Early Severe Illness TrAnslational BioLogy InformaticS in Humans

Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)

Effect of a Constructivist Educational Program on Preventing Ventilator-Associated Pneumonia in Intensive Care Units

Risk Factors of Ventilator-Associated Pneumonia in Critically Ill Population of Alexandria

Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

Inspiratory Work of Breathing Before and After Extubation